Subsequently to the publication of the above article, an interested reader drew to the authors' attention that the Nc‑control and si‑AKT1‑control data panels featured in Fig. 4A for the SW480 Transwell assay experiments on p. 2788 appeared to contain overlapping data, such that the data, which were intended to show the results from experiments performed under different experimental conditions, may have been derived from the same original source. Furthermore, in Fig. 5 on p. 2789, there appeared to be some overlapping data comparing the AKT1 western blotting data with the p‑AKT1 data, and the same data also appeared in Fig. 4D for the p‑AKT1 data presented there. The authors have re‑examined their original data, and have realized that these figures were assembled incorrectly; essentially, the si‑AKT1‑control data panel was selected incorrectly for Fig. 4A, and the authors were able to retrieve the original data for the western blots presented in Fig. 5. The corrected versions of Figs. 4 and 5 are shown on the next page. The authors confirm that these errors did not have any major impact on the conclusions reported in their paper, and are grateful to the Editor of Molecular Medicine Reports for allowing them this opportunity to publish a Corrigendum. Furthermore, the authors apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 20: 2783‑2795, 2019; DOI: 10.3892/mmr.2019.10528].
Keywords: AKT/GSK‑3β/Snail signaling; colon cancer; epithelialmesenchymal transition; metastasis; resveratrol.